U.S. markets open in 8 hours 59 minutes

Rexnord (RXN) in Focus: Stock Moves 9.8% Higher

Zacks Equity Research

Rexnord Corporation RXN was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 22.5% in the past one-month time frame.

The company has seen a mixed track record when it comes to estimate revisions of no increase and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Rexnord currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Rexnord Corporation Price

Rexnord Corporation Price

Rexnord Corporation price | Rexnord Corporation Quote

Investors interested in the Manufacturing - Electronics industry may consider Regal Beloit Corporation RBC, which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regal Beloit Corporation (RBC) : Free Stock Analysis Report
 
Rexnord Corporation (RXN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research